Ribbon 3D model of Yeast Fatty Acid Synthase.
|PDB structures||RCSB PDB PDBe PDBsum|
|Gene Ontology||AmiGO / EGO|
Fatty-acyl-CoA Synthase, or more commonly known as yeast fatty acid synthase (and not to be confused with Long Chain fatty acyl-CoA synthetase), is an enzyme complex responsible for fatty acid biosynthesis, and is of Type I Fatty Acid Synthesis (FAS). Yeast fatty acid synthase plays a pivotal role in fatty acid synthesis. It is a 2.6 MDa barrel shaped complex and is composed of two, unique multi-functional subunits: alpha and beta. Together, the alpha and beta units are arranged in an α6β6 structure. The catalytic activities of this enzyme complex involves a coordination system of enzymatic reactions between the alpha and beta subunits. The enzyme complex therefore consists of six functional centers for fatty acid synthesis.
The enzyme catalyzes the reaction:
Acetyl-CoA + n malonyl-CoA + 4n NADPH + 4n H+ long-chain-acyl-CoA + n CoA + n CO2 + 4n NADP+
Synthesis of fatty acids is generally performed by fatty acid synthase (FAS). Though the syntheses of fatty acids are very similar across all organisms, the enzymes and subsequent enzymatic mechanisms involved in fatty acid synthesis vary between eukaryotes and prokaryotes. There are two types of fatty acid synthesis (FAS) mechanisms: type I FAS and type II FAS. Type I FAS exists in eukaryotes, including mammalian cells and fungi. Type II FAS are found in prokaryotes. The type I FAS system utilizes a multi-enzyme complex, which are highly integrated, while the type II FAS system utilizes individual, separate enzymes to catalyze the reactions involved in fatty acid synthesis. Yeast fatty acyl synthase belongs to the Type I FAS and was the first of Type I FAS to be studied.
Yeast fatty acyl synthase, of Type I FAS, is composed of a α6β6 complex in which an αβ unit forms one functional center for fatty acid synthesis. Yeast fatty acyl synthase therefore has six reaction units for its fatty acid synthesis, in which each of these units function independently from one another. Each α and β subunit, in turn, has four functional domains, and together, the eight functional domains catalyze all the reactions of fatty acid synthesis in yeast, which includes: activation, priming, elongation, and termination. Consequently, yeast FAS is incredibly unique due to its structural complexity, which contains 48 functional centers for one α6β6 complex and can efficiently performs 6 fatty acid syntheses separately at one time.
There are seven, total enzymatic reactions in fatty acid synthesis. These reactions include: activation, priming, four reactions in elongation, and termination. Five these reactions are performed in the beta subunit and two reactions are performed in the alpha subunit.
The activation of yeast FAS occurs in the alpha subunit. The reaction is performed by the phosphopantetheinyl transferase (PPT) domain. PPT attaches the 4′-phosphopantetheine prosthetic group of CoA to the acyl carrier protein (ACP) domain, which is found in the N terminus of the α subunit. ACP is the only “mobile” domain of the enzyme complex, in which it moves intermediate substrates along all of the catalytic centers the enzyme, most notably the alpha and beta subunits.
The next step is priming, or the initiation of fatty acid synthesis. Priming is performed in the β subunit, and is catalyzed by the acetyltransferase (AT) domain, which initiates the process of fatty acid synthesis. Here, acetyltransferase transfers the acetate group from acetyl-CoA onto the SH group of the 4′-phosphopantetheine prosthetic group of ACP, which had been attached during activation.
Elongation involves four main reactions:
- The acetyl unit on ACP is condensed with malonyl-ACP to form β-ketobutyryl-ACP
- Ketobutyryl-ACP is then reduced by ketoacyl-ACP reductase to afford β-hydroxyacyl-ACP
- β-hydroxyacyl-ACP is then dehydrated to produce enoyl-ACP
- Enoyl-ACP is then reduced by enoyl reductase (ER) to form a saturated acyl-ACP, which can be elongated again in a new cycle of elongation
Elongation itself occurs in mainly in the α subunit, though the entire process required for elongation is a coordinated system which involves the α and β subunits. ACP first delivers the acetate group, which had been attached during priming, to the ketoacyl synthase (KS) domain in the α subunit (Figure 1A, reaction 3). ACP then moves back to the β subunit to the malonyl transacylase (MPT) domain and binds to a malonyl of malonyl-CoA, which will be used for elongation. The newly bound malonyl-ACP then swings back to the KS domain and transfers the malonate group for chain elongation. Now in the KS domain, the bound acyl group is condensed with the malonate to form 3-ketoacyl intermediate: β-ketobutyryl-ACP, releasing carbon dioxide in the process.
In the α subunit is also the ketoacyl reductase (KR) domain. The KR domain is NADPH dependent, and catalyzes substrate reduction, in which ketobutyryl-ACP is reduced to β-hydroxyacyl-ACP by NADPH.
The β-hydroxyacyl-ACP is then transferred back to the β subunit, where it is dehydrated in dehydratase (DH) domain. Another reduction reaction then performed in the enoyl reductase (ER) domain of the β subunit to form a saturated acyl-ACP chain. Finally, ACP brings the substrate back to the KS domain of the α subunit for another cycle of elongation. The elongation cycle is often repeated 3 more times before termination.
Once the fatty acid chain reaches 16 or 18 carbons long after cycles of elongation, termination occurs. In the final round of elongation, rather than being taken back to the KS domain, the fatty acid product, which is still bound to ACP, is taken from the ER domain to the MPT domain. Here, CoA is attached to the fatty acid, and the resulting long chain fatty acyl-CoA is released into the cytosol.
Fatty acids are key components of a cell, therefore, the regulation or inhibition of fatty acid synthesis hold severe consequences for cellular function. The malfunction of the fatty acid synthesis pathway can result in cancer and obesity. However, the significance of fatty acid synthesis also make the fatty acid synthesis pathway a potential target for the search and study of anticancer and antibiotic drugs. It has been found that in humans, fatty acid synthase, is overly expressed in cancer cells. Therefore, FAS, which has been associated only with energy production prior, is now associated with aggressive tumor growth and survival. Studies have also found that human fatty acid synthase is overly expressed in prostate cancer cells.
- "Structural Insights of Yeast Fatty Acid Synthase". PDB.
- Gipson P, Mills DJ, Wouts R, Grininger M, Vonck J, Kühlbrandt W (May 2010). "Direct structural insight into the substrate-shuttling mechanism of yeast fatty acid synthase by electron cryomicroscopy". Proc. Natl. Acad. Sci. U.S.A. 107 (20): 9164–9. doi:10.1073/pnas.0913547107. PMC . PMID 20231485.
- Singh N, Wakil SJ, Stoops JK (November 1985). "Yeast fatty acid synthase: structure to function relationship". Biochemistry. 24 (23): 6598–602. doi:10.1021/bi00344a044. PMID 3910094.
- Stoops JK, Singh N, Wakil SJ (October 1990). "The yeast fatty acid synthase. Pathway for transfer of the acetyl group from coenzyme A to the Cys-SH of the condensation site". J. Biol. Chem. 265 (28): 16971–7. PMID 2211602.
- Mohamed AH, Chirala SS, Mody NH, Huang WY, Wakil SJ (September 1988). "Primary structure of the multifunctional alpha subunit protein of yeast fatty acid synthase derived from FAS2 gene sequence". J. Biol. Chem. 263 (25): 12315–25. PMID 2900835.
- Advanced Light Source. "A First Look at Yeast Fatty Acid Synthase". Lawrence Berkeley National Laboratory, U.S. Department of Energy.
- Lomakin IB, Xiong Y, Steitz TA (April 2007). "The crystal structure of yeast fatty acid synthase, a cellular machine with eight active sites working together". Cell. 129 (2): 319–32. doi:10.1016/j.cell.2007.03.013. PMID 17448991.
- "MetaCyc fatty acids biosynthesis (yeast)". MetaCyc. SRI International.
- Leibundgut M, Jenni S, Frick C, Ban N (April 2007). "Structural basis for substrate delivery by acyl carrier protein in the yeast fatty acid synthase". Science. 316 (5822): 288–90. doi:10.1126/science.1138249. PMID 17431182.
- Wakil, Salih; Stoops, J.; Joshi, V. (1983). "Fatty Acid Synthesis and Its Regulation". Annu. Rev. Biochem. 52: 537–579. doi:10.1146/annurev.bi.52.070183.002541. PMID 6137188. Retrieved March 1, 2013.
- Kuhajda, Francis (March 2000). "Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology". Nutrition. 16 (3): 202–208. doi:10.1016/s0899-9007(99)00266-x.
- Baron, Antonella; et al. (January 2004). "Fatty acid synthase: A metabolic oncogene in prostate cancer". Journal of Cellular Biochemistry. 91 (1): 47–53. doi:10.1002/jcb.10708. PMID 14689581.
- Schweizer E, Kniep B, Castorph H, Holzner U (1973). "Pantetheine-free mutants of the yeast fatty-acid-synthetase complex". Eur. J. Biochem. 39 (2): 353–62. doi:10.1111/j.1432-1033.1973.tb03133.x. PMID 4590449.
- Wakil SJ, Stoops JK, Joshi VC (1983). "Fatty acid synthesis and its regulation". Annu. Rev. Biochem. 52: 537–79. doi:10.1146/annurev.bi.52.070183.002541. PMID 6137188.